MiMedx Group, Inc. (MDXG) stock
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3036% below fair value
$3.05−0.06 (-1.93%)
Close on Nov 20, 2026Market cap $445.07MP/E –Yield –
MiMedx net income
Net income is the profit left for shareholders after every expense, interest and tax.
MiMedx's net income for the twelve months ending Sep 30, 2026 was -$19.19M, down 147.0% year over year. For fiscal 2025 it was $48.58M, up 14.5% from the year before. Over ten years it grew 5.1% a year on average. The highest annual figure on record is $64.73M in fiscal 2017.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $48.58M | +14.5% |
| FY2024 | Dec 31, 2024 | $42.42M | -27.2% |
| FY2023 | Dec 31, 2023 | $58.23M | – |
| FY2022 | Dec 31, 2022 | -$30.20M | – |
| FY2021 | Dec 31, 2021 | -$10.29M | – |
| FY2020 | Dec 31, 2020 | -$49.28M | – |
| FY2019 | Dec 31, 2019 | -$25.58M | – |
| FY2018 | Dec 31, 2018 | -$29.98M | -146.3% |
| FY2017 | Dec 31, 2017 | $64.73M | +16496.7% |
| FY2016 | Dec 31, 2016 | $390.00K | -98.7% |
| FY2015 | Dec 31, 2015 | $29.45M | +373.4% |
| FY2014 | Dec 31, 2014 | $6.22M | – |
| FY2013 | Dec 31, 2013 | -$4.11M | – |
| FY2012 | Dec 31, 2012 | -$7.66M | – |
| FY2011 | Dec 31, 2011 | -$10.19M | – |
| FY2010 | Dec 31, 2010 | -$11.42M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$8.68M | -151.8% |
| Q2 FY2026 | Jun 30, 2026 | -$14.84M | -254.3% |
| Q1 FY2026 | Mar 31, 2026 | -$10.86M | -254.6% |
| Q4 FY2025 | Dec 31, 2025 | $15.19M | +104.2% |
| Q3 FY2025 | Sep 30, 2025 | $16.75M | +106.9% |
| Q2 FY2025 | Jun 30, 2025 | $9.62M | -45.4% |
| Q1 FY2025 | Mar 31, 2025 | $7.02M | -24.2% |
| Q4 FY2024 | Dec 31, 2024 | $7.44M | -86.1% |
| Q3 FY2024 | Sep 30, 2024 | $8.10M | -5.1% |
| Q2 FY2024 | Jun 30, 2024 | $17.63M | +1368.8% |
| Q1 FY2024 | Mar 31, 2024 | $9.26M | – |
| Q4 FY2023 | Dec 31, 2023 | $53.48M | – |
| Q3 FY2023 | Sep 30, 2023 | $8.53M | – |
| Q2 FY2023 | Jun 30, 2023 | $1.20M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.98M | – |
| Q4 FY2022 | Dec 31, 2022 | -$414.00K | -118.7% |
| Q3 FY2022 | Sep 30, 2022 | -$8.43M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.87M | – |
| Q1 FY2022 | Mar 31, 2022 | -$10.49M | – |
| Q4 FY2021 | Dec 31, 2021 | $2.22M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.34M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.78M | – |
| Q1 FY2021 | Mar 31, 2021 | -$8.38M | – |
| Q4 FY2020 | Dec 31, 2020 | -$16.58M | – |
| Q3 FY2020 | Sep 30, 2020 | -$19.42M | -256.9% |
| Q2 FY2020 | Jun 30, 2020 | -$8.47M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.82M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.48M | – |
| Q3 FY2019 | Sep 30, 2019 | $12.38M | – |
| Q2 FY2019 | Jun 30, 2019 | -$17.21M | -1054.0% |
| Q1 FY2019 | Mar 31, 2019 | -$13.27M | -387.4% |
| Q4 FY2018 | Dec 31, 2018 | -$36.22M | -947.1% |
| Q3 FY2018 | Sep 30, 2018 | -$178.00K | -100.4% |
| Q2 FY2018 | Jun 30, 2018 | $1.80M | -82.7% |
| Q1 FY2018 | Mar 31, 2018 | $4.62M | -23.0% |
| Q4 FY2017 | Dec 31, 2017 | $4.28M | -22.0% |
| Q3 FY2017 | Sep 30, 2017 | $44.05M | – |
| Q2 FY2017 | Jun 30, 2017 | $10.40M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.48M | – |
See a number that looks wrong?